Why I’m Excited About Aducanumab (Aduhelm)!
In this episode of Evolving Past Alzheimer’s, Dr. Nate Bergman quickly summarizes the story up the FDA’s recent “accelerated approval” of Biogen’s – Aducanumab (brand named, Aduhelm). He ends off …
Aducanumab – Is this the end of Alzheimer’s? Not just yet…
It’s been 18 years since the last drug was approved for Alzheimer’s, but on Monday, June 7, 2021, the FDA gave “Accelerated Approval” to Biogen’s novel medication, Aducanumab (“Aduhelm”). The …
Aducanumab – Is this the end of Alzheimer’s? Not just yet… Read More »
